Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 1
2020 2
2021 5
2022 5
2023 3
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Thoracic re-irradiation with 3D-conformal or more advanced techniques: A systematic review of treatment safety by the Re-irradiation Study Group of the Italian Association of Radiation and Oncology AIRO.
Maddalo M, D'Angelo E, Fiorica F, Argenone A, Scricciolo M, Cozzi S, Nardangeli A, Dionisi F, Costantino G, Vagge S, Pontoriero A, Donato V, Massaccesi M; Re-irradiation Study Group of the Italian Association of Radiation Oncology. Maddalo M, et al. Among authors: nardangeli a. Crit Rev Oncol Hematol. 2021 Nov;167:103500. doi: 10.1016/j.critrevonc.2021.103500. Epub 2021 Oct 21. Crit Rev Oncol Hematol. 2021. PMID: 34688894 Review.
Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy.
Autorino R, Gui B, Panza G, Boldrini L, Cusumano D, Russo L, Nardangeli A, Persiani S, Campitelli M, Ferrandina G, Macchia G, Valentini V, Gambacorta MA, Manfredi R. Autorino R, et al. Among authors: nardangeli a. Radiol Med. 2022 May;127(5):498-506. doi: 10.1007/s11547-022-01482-9. Epub 2022 Mar 24. Radiol Med. 2022. PMID: 35325372 Free PMC article. Review.
Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups.
Macchia G, Nardangeli A, Laliscia C, Fodor A, Draghini L, Gentile PC, D'Agostino GR, Balcet V, Bonome P, Ferioli M, Autorino R, Vicenzi L, Raguso A, Borghesi S, Ippolito E, Di Cataldo V, Cilla S, Perrucci E, Campitelli M, Gambacorta MA, Deodato F, Scambia G, Ferrandina G. Macchia G, et al. Among authors: nardangeli a. Int J Gynecol Cancer. 2022 Jun 6;32(6):732-739. doi: 10.1136/ijgc-2021-003237. Int J Gynecol Cancer. 2022. PMID: 35193941
Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients.
Mattiucci GC, Boldrini L, Nardangeli A, D'Aviero A, Buwenge M, Cellini F, Deodato F, Dinapoli N, Frascino V, Macchia G, Morganti AG, Valentini V. Mattiucci GC, et al. Among authors: nardangeli a. J Cancer Res Clin Oncol. 2021 Mar;147(3):661-667. doi: 10.1007/s00432-020-03411-7. Epub 2020 Oct 1. J Cancer Res Clin Oncol. 2021. PMID: 33001271
Nasopharyngeal cancer: the impact of guidelines and teaching on radiation target volume delineation.
Dionisi F, Di Rito A, Errico A, Iaccarino G, Farneti A, D'Urso P, Nardangeli A, Bambace S, D'Onofrio I, D'Angelo E, De Felice F, Fanetti G, Belgioia L, Alterio D, Orlandi E, Merlotti A, Musio D, Sanguineti G. Dionisi F, et al. Among authors: nardangeli a. Radiol Med. 2023 Mar;128(3):362-371. doi: 10.1007/s11547-023-01612-x. Epub 2023 Mar 6. Radiol Med. 2023. PMID: 36877421
Outcomes and toxicities of re-irradiation for prostate cancer: A systematic review on behalf of the Re-Irradiation Working Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Munoz F, Fiorica F, Caravatta L, Rosa C, Ferella L, Boldrini L, Fionda B, Alitto AR, Nardangeli A, Dionisi F, Arcangeli S, Di Marzo A, Pontoriero A, Donato V, Massaccesi M. Munoz F, et al. Among authors: nardangeli a. Cancer Treat Rev. 2021 Apr;95:102176. doi: 10.1016/j.ctrv.2021.102176. Epub 2021 Mar 8. Cancer Treat Rev. 2021. PMID: 33743409
Pretreatment MRI Radiomics Based Response Prediction Model in Locally Advanced Cervical Cancer.
Gui B, Autorino R, Miccò M, Nardangeli A, Pesce A, Lenkowicz J, Cusumano D, Russo L, Persiani S, Boldrini L, Dinapoli N, Macchia G, Sallustio G, Gambacorta MA, Ferrandina G, Manfredi R, Valentini V, Scambia G. Gui B, et al. Among authors: nardangeli a. Diagnostics (Basel). 2021 Mar 31;11(4):631. doi: 10.3390/diagnostics11040631. Diagnostics (Basel). 2021. PMID: 33807494 Free PMC article.
EROS 2.0 study: evaluation of two interventional radiotherapy (brachytherapy) schedules for endometrial cancer: a comparison of late vaginal toxicity rates.
Lancellotta V, Macchia G, Dinapoli N, Autorino R, Campitelli M, Nardangeli A, Salvati A, Fionda B, Casà C, Cornacchione P, Rovirosa A, Kovács G, Morganti AG, Ferrandina MG, Gambacorta MA, Tagliaferri L. Lancellotta V, et al. Among authors: nardangeli a. Radiol Med. 2022 Mar;127(3):341-348. doi: 10.1007/s11547-022-01455-y. Epub 2022 Jan 29. Radiol Med. 2022. PMID: 35092552 Free PMC article.
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images.
Cusumano D, Russo L, Gui B, Autorino R, Boldrini L, D'Erme L, Persiani S, Catucci F, Broggi S, Panza G, Nardangeli A, Campitelli M, Ferrandina G, Macchia G, Fiorino C, Valentini V, Scambia G, Manfredi R, Gambacorta MA. Cusumano D, et al. Among authors: nardangeli a. Radiother Oncol. 2022 Sep;174:30-36. doi: 10.1016/j.radonc.2022.07.001. Epub 2022 Jul 8. Radiother Oncol. 2022. PMID: 35811004
16 results